
Novartis NVS is a multinational pharmaceutical company that has been a leader in the industry for decades. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a rich history of innovation and growth.
The company's name, Novartis, is derived from the Latin words "novus", meaning new, and "ars", meaning art or science. This name reflects the company's mission to harness the power of science to create new medicines and improve human health.
Headquartered in Basel, Switzerland, Novartis has a global presence with operations in over 140 countries. Its research and development efforts have led to the creation of numerous groundbreaking medicines, including the first multiple sclerosis treatment and the first lung cancer treatment to show improved survival rates.
For your interest: Lookup Stock Symbol by Company Name
Dividend Calendar
Novartis has a consistent dividend payout history, with the company paying out dividends every year since 2009.
The dividend payout has been steadily increasing over the years, with the highest payout of $3.96 in 2024.
You might enjoy: Stock Symbol B
In 2017, Novartis paid out a dividend of $2.49, which is a significant increase from the $1.65 paid out in 2009.
Here's a breakdown of the dividend payouts for Novartis over the years:
The dividend yield has also fluctuated over the years, with the highest yield of 3.96% in 2024 and the lowest yield of 2.12% in 2019.
Novartis' dividend payout has been a reliable source of income for investors, with the company consistently paying out dividends every year since 2009.
Frequently Asked Questions
Is Novartis a good stock to buy now?
Novartis has a Moderate Buy rating with an average price target of $140.50, indicating potential growth, but it's essential to research and consider multiple factors before making an investment decision.
Is Novartis listed in the US?
Yes, Novartis is listed in the US, specifically on the New York Stock Exchange under the trading symbol "NVS". Its shares are priced in US dollars.
What is the 5 year return for Novartis?
The 5-year total return for Novartis is 22.6%, calculated from a last close price of $97.11 and an adjusted prior close price of $79.20.
Featured Images: pexels.com